OMX Copenhagen 25 GI (OMXC25GI.CO)

Close: 1 518.33 (+3.96), Jul 10, 2020
Positive

Low risk

Automatic technical analysis. Medium term, Jul 10, 2020

Investors have paid higher prices over time to buy OMX Copenhagen 25 GI and the index is in a rising trend channel in the medium long term. This signals increasing optimism among investors and indicates continued rise. There is no resistance in the price chart and further rise is indicated. In case of a negative reaction, the index has support at approximately 1470 points. The short term momentum of the index is strongly positive, with RSI above 70. This indicates increasing optimism among investors and further price increase for OMX Copenhagen 25 GI. However, particularly for big stocks, high RSI may be a sign that the stock is overbought and that there is a chance of a reaction downwards. The index is overall assessed as technically positive for the medium long term.

Recommendation one to six months: Positive (Score: 88)

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-0.84%0.00+0.26%
5 days0.002.85%0.00+2.12%
22 days0.007.98%0.00+4.88%
66 days0.0017.09%0.00+27.79%

More analyses of OMX Copenhagen 25 GI

chart OMX Copenhagen 25 GI (OMXC25GI) Candlesticks 22 Days
Candlesticks
chart OMX Copenhagen 25 GI (OMXC25GI) Short term
Short term: Positive
chart OMX Copenhagen 25 GI (OMXC25GI) Medium term
Medium term: Positive
chart OMX Copenhagen 25 GI (OMXC25GI) Long term
Long term: Positive
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK